Loading
TP
TME Pharma N.V. Stock: price and insider trades · Netherlands
ISIN NL0015000YE1NL·
No insider purchase over the last 90 days. The latest was filed 30 Sept 2025.
TME Pharma N.V.: what insiders have been doing
TME Pharma N.V. is a listed company. Filings by its managers are published through AFM. The last twelve months, up to 18 October 2026, brought 7 filings signed by 5 insiders.
No insider bought on the market over the period, while 1 insider filed 3 sales totalling €384k. Biggest ticket of the year: €170k, sold by Ouden, van den D.M. and made public on 31 August 2026.
Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
For context, the typical company on the same exchange (median of 126 companies) published 7 filings over the same period, against 7 filings here. Since 2025, the database holds 5 purchases and 3 sales by insiders of the company.
These figures are compiled from regulatory filings published by AFM. They describe what insiders did and are not a recommendation.
Insider Decl.
13
Thresholds
n/a
Buy Volume
€59,500
5 ops. · all time
Sell Volume
€384,250
3 ops. · all time
Who traded when
BuySaleD.M. van den Ouden5 buys3 sales
Financial data
· cache
Last declaration on 7 October 2026
Declarations13 total
188,377 sharesOptieOTCAFM:MAR19:202609266D3B3517-E457-44F7-86A1-C6C1EE590164
188,377 sharesPersoneelsoptieOTCAFM:MAR19:20260929D6503CDC-DB02-4D6F-99C4-6A0374A4D9DE
188,377 sharesPersoneelsoptieOTCAFM:MAR19:2026092903AD6753-66F7-4C75-9A3F-20C6C8BAC61A
188,377 sharesPersoneelsoptieOTCAFM:MAR19:2026092904F61DE5-7114-4CD2-AE36-4826B490C8AF
-1,000,000 shares@ €0.1744.2% of flowGewoon aandeelEURONEXT - EURONEXT PARISISIN NL0015000YE1AFM:MAR19:20260826BEFA4FA2-46D5-4B0E-A5B4-3FD2456D66F8
-1,214,950 shares@ €0.134742.6% of flowGewoon aandeelEURONEXT - EURONEXT PARISISIN NL0015000YE1AFM:MAR19:20260824EA324A3F-F82C-4EE7-A17B-2ACE8A0CEA47
-460,050 shares@ €0.1113.2% of flowGewoon aandeelEURONEXT - EURONEXT PARISISIN NL0015000YE1AFM:MAR19:202608192EDF5FD3-8B67-40F0-99CC-44293C117A0D
50,000 shares@ €0.101.1% of flowGewoon aandeelEURONEXT - EURONEXT PARISISIN NL0015000YE1AFM:MAR19:202509269B4588A2-A5E7-4EF3-B71D-5BFE53738DF2
135,000 shares@ €0.103.0% of flowGewoon aandeelEURONEXT - EURONEXT PARISISIN NL0015000YE1AFM:MAR19:202509256EFC75F1-B730-4D0F-A115-7F330EC44E13
Canonical exit: 24 Dec 2025 (T+90)
65,000 shares@ €0.101.4% of flowGewoon aandeelEURONEXT - EURONEXT PARISISIN NL0015000YE1AFM:MAR19:20250924EA650CE7-D6F6-4D9A-B379-99005F557E75
Canonical exit: 23 Dec 2025 (T+90)
30,000 shares@ €0.100.7% of flowGewoon aandeelEURONEXT - EURONEXT PARISISIN NL0015000YE1AFM:MAR19:2025092340CF9254-9D6E-4D18-B60F-FC6E5A43D500
Canonical exit: 22 Dec 2025 (T+90)
95,000 shares@ €0.102.1% of flowGewoon aandeelEURONEXT - EURONEXT PARISISIN NL0015000YE1AFM:MAR19:202509229BCF75FF-E0C5-4F50-AC80-5445F5DB481D
Canonical exit: 21 Dec 2025 (T+90)
300,000 shares@ €0.096.0% of flowGewoon aandeelEURONEXT - EURONEXT PARISISIN NL0015000YE1AFM:MAR19:2025091926567FA4-84D3-453A-850D-6749F8CC1ABD
Canonical exit: 18 Dec 2025 (T+90)
13 of 13 declarations
About TME Pharma N.V.
TME Pharma N.V. is a biopharmaceutical company focused on developing treatments for hard-to-treat cancers. It is listed on the Amsterdam Stock Exchange (XAMS).
